• Author: Solanus de la Serna
Clear all

Optimizing utilization of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease in a VA primary care clinic: An interdisciplinary quality improvement project

Abstract: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce the progression of chronic kidney disease (CKD) to end-stage renal disease, doubling of creatinine, and death …